Roles of Cathelicidins in Inflammation and Bone Loss

Overview

Journal Odontology

Specialty Dentistry

Date 2014 Jul 23

PMID 25047111

Citations 16

Authors

Yuko Nakamichi

Kanji Horibe

Naoyuki Takahashi

Nobuyuki Udagawa

Affiliations

Soon will be listed here.

Abstract

Body surface tissues, such as the oral cavity, contact directly with the external environment and are continuously exposed to microbial insults. Cathelicidins are a family of antimicrobial peptides that are found in mammalian species. Humans and mice have only one cathelicidin. Cathelicidins are expressed in a variety of surface tissues. In addition, they are abundantly expressed in bone and bone marrow. Infectious stimuli upregulate the expression of cathelicidins, which play sentinel roles in allowing the tissues to fight against microbial challenges. Cathelicidins disrupt membranes of microorganisms and kill them. They also neutralize microbe-derived pathogens, such as lipopolysaccharide (LPS) and flagellin. Besides their antimicrobial functions, cathelicidins can also control actions of host cells, such as chemotaxis, proliferation, and cytokine production, through binding to the receptors expressed on them. LPS and flagellin induce osteoclastogenesis and the production of cathelicidins, which can in turn inhibit osteoclastogenesis. Thus, cathelicidins contribute to maintaining microbiota-host homeostasis and promoting repair responses to inflammatory insults. In this review, we describe recent findings on the multiple roles of cathelicidins in host defense. We also discuss the significance of the human cathelicidin, LL-37, as a pharmaceutical target for the treatment of inflammation and bone loss in infectious diseases, such as periodontitis.

Citing Articles

Bacteriostatic and Immunomodulatory Effect of Xylocaine in the Context of Bladder Epithelial Cell Infection.

White J, Yin Y, Mohanty S, Ferraz N, Brauner A ACS Bio Med Chem Au. 2025; 5(1):31-34.

PMID: 39990940 PMC: 11843344. DOI: 10.1021/acsbiomedchemau.4c00070.

Local Defense Factors in Cleft-Affected Palate in Children before and during Milk Dentition Age: A Pilot Study.

Ozola L, Pilmane M J Pers Med. 2024; 14(1).

PMID: 38248728 PMC: 10817640. DOI: 10.3390/jpm14010027.

Dual-functional composite scaffolds for inhibiting infection and promoting bone regeneration.

Cui Y, Liu H, Tian Y, Fan Y, Li S, Wang G Mater Today Bio. 2022; 16:100409.

PMID: 36090611 PMC: 9449864. DOI: 10.1016/j.mtbio.2022.100409.

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity.

Tokajuk J, Deptula P, Piktel E, Daniluk T, Chmielewska S, Wollny T Biomedicines. 2022; 10(5).

PMID: 35625823 PMC: 9138798. DOI: 10.3390/biomedicines10051086.

Cathelicidin LL-37 improves bone metabolic balance in rats with ovariectomy-induced osteoporosis via the Wnt/beta-catenin pathway.

Liang J, Chen J, Ye Z, Bao D Physiol Res. 2022; 71(3):369-377.

PMID: 35616038 PMC: 9470098. DOI: 10.33549/physiolres.934820.

References

Puklo M, Guentsch A, Hiemstra P, Eick S, Potempa J . Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria. Oral Microbiol Immunol. 2008; 23(4):328-35. PMC: 2565510. DOI: 10.1111/j.1399-302X.2008.00433.x. View

Sato N, Takahashi N, Suda K, Nakamura M, Yamaki M, Ninomiya T . MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha. J Exp Med. 2004; 200(5):601-11. PMC: 2212746. DOI: 10.1084/jem.20040689. View

Kandler K, Shaykhiev R, Kleemann P, Klescz F, Lohoff M, Vogelmeier C . The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int Immunol. 2006; 18(12):1729-36. DOI: 10.1093/intimm/dxl107. View

Rosenberger C, Gallo R, Finlay B . Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc Natl Acad Sci U S A. 2004; 101(8):2422-7. PMC: 356966. DOI: 10.1073/pnas.0304455101. View

Coffelt S, Tomchuck S, Zwezdaryk K, Danka E, Scandurro A . Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells. Mol Cancer Res. 2009; 7(6):907-15. PMC: 2755540. DOI: 10.1158/1541-7786.MCR-08-0326. View

McCrudden M, Orr D, Yu Y, Coulter W, Manning G, Irwin C . LL-37 in periodontal health and disease and its susceptibility to degradation by proteinases present in gingival crevicular fluid. J Clin Periodontol. 2013; 40(10):933-41. DOI: 10.1111/jcpe.12141. View

Ong P, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T . Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002; 347(15):1151-60. DOI: 10.1056/NEJMoa021481. View

Mookherjee N, Brown K, Bowdish D, Doria S, Falsafi R, Hokamp K . Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol. 2006; 176(4):2455-64. DOI: 10.4049/jimmunol.176.4.2455. View

Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang Y, Homey B . Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007; 449(7162):564-9. DOI: 10.1038/nature06116. View

10.

Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

11.

Kahlenberg J, Carmona-Rivera C, Smith C, Kaplan M . Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J Immunol. 2012; 190(3):1217-26. PMC: 3552129. DOI: 10.4049/jimmunol.1202388. View

12.

Wade W . The oral microbiome in health and disease. Pharmacol Res. 2012; 69(1):137-43. DOI: 10.1016/j.phrs.2012.11.006. View

13.

Lomaga M, Yeh W, Sarosi I, Duncan G, Furlonger C, Ho A . TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 1999; 13(8):1015-24. PMC: 316636. DOI: 10.1101/gad.13.8.1015. View

14.

Nomura I, Goleva E, Howell M, Hamid Q, Ong P, Hall C . Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol. 2003; 171(6):3262-9. DOI: 10.4049/jimmunol.171.6.3262. View

15.

Supanchart C, Thawanaphong S, Makeudom A, Bolscher J, Nazmi K, Kornak U . The antimicrobial peptide, LL-37, inhibits in vitro osteoclastogenesis. J Dent Res. 2012; 91(11):1071-7. DOI: 10.1177/0022034512460402. View

16.

Rosenfeld Y, Papo N, Shai Y . Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J Biol Chem. 2005; 281(3):1636-43. DOI: 10.1074/jbc.M504327200. View

17.

Turkoglu O, Emingil G, Kutukculer N, Atilla G . Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis. J Periodontol. 2009; 80(6):969-76. DOI: 10.1902/jop.2009.080532. View

18.

Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, Ehren I . The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med. 2006; 12(6):636-41. DOI: 10.1038/nm1407. View

19.

Nizet V, Gallo R . Cathelicidins and innate defense against invasive bacterial infection. Scand J Infect Dis. 2003; 35(9):670-6. DOI: 10.1080/00365540310015629. View

20.

Gallo R, Kim K, Bernfield M, Kozak C, Zanetti M, Merluzzi L . Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem. 1997; 272(20):13088-93. DOI: 10.1074/jbc.272.20.13088. View